Morning Briefing
Summaries of health policy coverage from major news organizations
Daily Oral Antiretroviral Reduces HIV Infection Risk In MSM By 44%, Study Finds
A study that included nearly 2,500 HIV-negative men and transgender women who have sex with men has shown that a daily dose of Truvada, a pill containing the AIDS drugs emtricitabine and tenofovir, "can reduce risk of contracting [HIV] by an average of 44%
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
